2025 annual financial data
MaxCyte 2025 Operating margin
Direct answer
Operating margin was -137.12%.
Operating income was -45,285,000 USD and net income was -44,630,000 USD.
Operating cash flow was -34,410,000 USD.
Get free MaxCyte email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 33,026,000 USD
- Operating income
- -45,285,000 USD
- Net income
- -44,630,000 USD
- Operating cash flow
- -34,410,000 USD